JANX (STOCKS)
Janux Therapeutics, Inc. Common Stock
$16.000000
-0.670000 (-4.02%)
Prev close: $16.670000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David Campbell
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,062.39M
- Employees
- 103
- P/E (TTM)
- -10.14
- P/B (TTM)
- 1.10
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
12
Buy
4
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.35 | $-0.39 | +0.0420 | +10.71% |
|
Mar 2026 (Q1)
|
$-0.39 | $-0.54 | +0.1469 | +27.36% |
|
Dec 2025 (Q4)
|
$-0.51 | $-0.66 | +0.1471 | +22.39% |
|
Sep 2025 (Q3)
|
$-0.39 | $-0.63 | +0.2397 | +38.07% |
Financial Statements
| Revenues | $24.00M |
| Benefits Costs and Expenses | $126.59M |
| Costs And Expenses | $126.59M |
| Nonoperating Income/Loss | $40.96M |
| Operating Expenses | $167.56M |
| Research and Development | $123.98M |
| Other Operating Expenses | $43.57M |
| Operating Income/Loss | -$143.56M |
| Income/Loss From Continuing Operations After Tax | -$102.59M |
| Income/Loss From Continuing Operations Before Tax | -$102.59M |
| Net Income/Loss | -$102.59M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$102.59M |
| Net Income/Loss Available To Common Stockholders, Basic | -$102.59M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.64 |
| Diluted Earnings Per Share | -$1.64 |
| Basic Average Shares | 187,686,907 |
| Diluted Average Shares | 124,886,151 |
| Assets | $1.01B |
| Current Assets | $983.34M |
| Accounts Receivable | $149.00K |
| Other Current Assets | $983.19M |
| Noncurrent Assets | $24.32M |
| Fixed Assets | $3.26M |
| Other Non-current Assets | $21.06M |
| Liabilities | $79.67M |
| Current Liabilities | $60.15M |
| Accounts Payable | $3.02M |
| Wages | $3.10M |
| Other Current Liabilities | $54.03M |
| Noncurrent Liabilities | $19.52M |
| Equity | $927.98M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $927.98M |
| Liabilities And Equity | $1.01B |
| Net Cash Flow From Operating Activities | -$41.25M |
| Net Cash Flow From Operating Activities, Continuing | -$41.25M |
| Net Cash Flow From Investing Activities | $7.35M |
| Net Cash Flow From Investing Activities, Continuing | $7.35M |
| Net Cash Flow From Financing Activities | $9.22M |
| Net Cash Flow From Financing Activities, Continuing | $9.22M |
| Net Cash Flow | -$24.68M |
| Net Cash Flow, Continuing | -$24.68M |
| Comprehensive Income/Loss | -$108.64M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$108.64M |
| Other Comprehensive Income/Loss | -$6.05M |